Skip to content

Argyreia nervosa exposures reported to Texas poison centers.

Mathias B. Forrester

Journal of Addictive Diseases 2018 DOI: 10.1080/10550887.2019.1640057 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Retrospective case series Case report Peer reviewed
Sample size 29
Population People with Argyreia nervosa (Hawaiian baby woodrose) seed exposures reported to Texas poison centers, 2000-2018
Keywords Argyreia nervosa Hawaiian baby woodrose Lysergic acid amine Poison center
Key findings Of 29 Argyreia nervosa seed exposures reported to Texas poison centers, 38% had moderate and 7% major medical effects, while 31% had minor effects and 3% no effect. Gastrointestinal (45%) and neurological (41%) effects were most frequent, and common treatments were intravenous fluids (28%) and benzodiazepines (21%).

Abstract

The seeds of Argyreia nervosa (Hawaiian baby woodrose) contain lysergamide or lysergic acid amine, an analog for lysergic acid diethylamide. Twenty-nine Argyreia nervosa exposures reported to Texas poison centers during 2000-2018 were identified. Seventy-nine percent of the patients were male; the mean age was 24 years (range 16-53 years). The exposure route was 97% ingestion and 3% inhalation. Ninety-three percent of the exposures occurred at the patient's own residence and 3% at another residence. Fourteen percent of the patients were managed on-site, 69% were already at or en route to a healthcare facility when the poison center was contacted, and 17% were referred to a healthcare facility by the poison center. The medical outcome was 3% no effect, 31% minor effect, 38% moderate effect, 7% major effect, 7% not followed-minimal clinical effects possible, and 14% unable to follow-potentially toxic. The most frequent clinical effects were gastrointestinal (45%) and neurological (41%). The most frequently reported treatments were administration of intravenous fluids (28%) and benzodiazepines (21%).

Citations in the library

Explore topics